BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 6978215)

  • 21. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.
    Wybran J; Fudenberg HH
    J Clin Invest; 1973 May; 52(5):1026-32. PubMed ID: 4540711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of lipoid nephrosis: a disorder of T-cell function.
    Shalhoub RJ
    Lancet; 1974 Sep; 2(7880):556-60. PubMed ID: 4140273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-mediated immunity in nephrotic syndrome.
    Mallick NP; Williams RJ; McFarlane H; Orr WM; Taylor G; Williams G
    Lancet; 1972 Mar; 1(7749):507-9. PubMed ID: 4110020
    [No Abstract]   [Full Text] [Related]  

  • 24. Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells.
    Ferrarini M; Moretta L; Abrile R; Durante ML
    Eur J Immunol; 1975 Jan; 5(1):70-2. PubMed ID: 1086217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A serum inhibitor of blastogenesis in idiopathic nephrotic syndrome transferred by lymphocytes.
    Iitaka K; West CD
    Clin Immunol Immunopathol; 1979 Jan; 12(1):62-71. PubMed ID: 421373
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of T lymphocyte function and inhibitory factors in minimal change nephrotic syndrome.
    Tomizawa S; Suzuki S; Oguri M; Kuroume T
    Nephron; 1979; 24(4):179-82. PubMed ID: 315034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary and secondary abnormalities of T cell subpopulations.
    Trompeter RS; Layward L; Hayward AR
    Clin Exp Immunol; 1978 Dec; 34(3):388-92. PubMed ID: 311259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein.
    Curtiss LK; Edgington TS
    J Immunol; 1976 May; 116(5):1452-8. PubMed ID: 178796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of kwashiorkor serum on lymphocyte transformation in vitro.
    Beatty DW; Dowdle EB
    Clin Exp Immunol; 1978 Apr; 32(1):134-43. PubMed ID: 149622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of lymphocyte blastogenesis by plasma of patients with minimal-change nephrotic syndrome.
    Moorthy AV; Zimmerman SW; Burkholder PM
    Lancet; 1976 May; 1(7970):1160-2. PubMed ID: 58203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for cell-mediated immunity to renal antigens in minimal-change nephrotic syndrome.
    Eyres K; Mallick NP; Taylor G
    Lancet; 1976 May; 1(7970):1158-9. PubMed ID: 58202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Lymphokines and nephrotic syndrome.
    Lagrue G; Xheneumont S; Branellec A; Weil B
    Lancet; 1975 Feb; 1(7901):271-2. PubMed ID: 46408
    [No Abstract]   [Full Text] [Related]  

  • 33. Cell mediated immunity in idiopathic glomerulonephritis.
    Sasdelli M; Cagnoli L; Candi P; Mandreoli M; Beltrandi E; Zucchelli P
    Clin Exp Immunol; 1981 Oct; 46(1):27-34. PubMed ID: 6978215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of immune glomerulonephritis].
    Rougier JP; Ronco P
    Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glomerulonephritis in neoplastic disease].
    Mazanowska O; Klinger M
    Pol Merkur Lekarski; 2005 Aug; 19(110):211-4. PubMed ID: 16245437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP
    J Nephrol; 1999; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cyclosporin A--mechanisms of its action and its potential in the treatment of idiopathic nephrotic syndrome].
    Robeva R
    Vutr Boles; 1988; 27(6):1-4. PubMed ID: 3073571
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C; Brosius FC; Palmieri J
    Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunopathogenesis of glomerulonephritis--the importance of new concepts for clinical practice].
    Klinger M
    Pol Arch Med Wewn; 1999 Jun; 101(6):547-52. PubMed ID: 10754743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.